Drug Enforcement Administration March 25, 2013 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV
Document Number: 2013-06651
Type: Proposed Rule
Date: 2013-03-25
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes the placement of 5[alpha]-pregnan-3[alpha]-ol-11,20-dione (alfaxalone) including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule IV of the Controlled Substances Act (CSA). This proposed action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking.